A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide Monotherapy Versus Apalutamide Plus Androgen Deprivation Therapy (ADT) in Participants Newly Diagnosed with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

1. Janssen Research & Development, LLC $14,305,712 1,200 payments

1. US Oncology Research INC Organisation paid for research $1,900,774 397 payments
2. Uropartners LLC Organisation paid for research $1,276,887 60 payments
3. Tristate Urologic Services Psc INC Dba Tug Research Organisation paid for research $1,157,414 31 payments
4. First Urology Psc Organisation paid for research $1,035,509 70 payments
5. Advanced Urology Pllc Organisation paid for research $939,602 46 payments
6. Michigan Institute of Urology Organisation paid for research $938,248 56 payments
7. Urology Centers Of Alabama Organisation paid for research $938,143 43 payments
8. Associated Medical Professionals Of Ny Pllc Organisation paid for research $828,939 47 payments
9. Urology Of Indiana Organisation paid for research $735,682 58 payments
10. The University Of Texas Southwester N Medical Center Organisation paid for research $605,570 57 payments

Usually the institution or organisation running the study, not a person.